Australia To Consider New Drug Price Caps In Next Year’s Budget
This article was originally published in PharmAsia News
Australia's federal government plans to lower the caps on the price of the medicines it covers when it considers next year's budget later this year. Drug makers are being advised by the Health Ministry that the budget might go after company profits if the current practice of discounts and incentives to pharmacists to push drugs is not restrained. The discounts get passed on to the consumer, Minister Nicola Roxon said, and the government does not feel the Pharmaceutical Benefits Scheme should be propping up industry profits, particularly in the current economic climate. (Click here for more
You may also be interested in...
Coverage Decisions For AlloMap Molecular Testing To Detect Cardiac Allograft Rejections Left Up To MACs
The US CMS has proposed that due to low Medicare use, it will not nationally cover AlloMap molecular tests to detect cardiac allograft rejections.
Manufacturers considering use of the popular 99.99% germ-kill claim on hand sanitizer products should consult the Office of Compliance, said Division of Nonprescription Drug Products director Theresa Michele during a recent industry workshop. “Be very, very cautious about the claims you are making,” she said.
Change in leadership at the European Medicines Agency comes at a critical time.